V. HAZAR Et Al. , "High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation," BONE MARROW TRANSPLANTATION , vol.33, no.9, pp.931-935, 2004
HAZAR, V. Et Al. 2004. High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation. BONE MARROW TRANSPLANTATION , vol.33, no.9 , 931-935.
HAZAR, V., Kansoy, S., Kupesiz, A., Aksoylar, S., KANTAR, M., & Yesilipek, A., (2004). High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation. BONE MARROW TRANSPLANTATION , vol.33, no.9, 931-935.
HAZAR, Volkan Et Al. "High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation," BONE MARROW TRANSPLANTATION , vol.33, no.9, 931-935, 2004
HAZAR, Volkan Et Al. "High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation." BONE MARROW TRANSPLANTATION , vol.33, no.9, pp.931-935, 2004
HAZAR, V. Et Al. (2004) . "High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation." BONE MARROW TRANSPLANTATION , vol.33, no.9, pp.931-935.
@article{article, author={Volkan HAZAR Et Al. }, title={High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation}, journal={BONE MARROW TRANSPLANTATION}, year=2004, pages={931-935} }